NCT03220048View on ClinicalTrials.gov

Study Examining PrEP-001 in Healthy Subjects

PHASE2CompletedINTERVENTIONAL

Enrollment

66

Participants

Timeline

Start Date

September 16, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Influenza A H3N2

Interventions

DRUG

PrEP-001

OTHER

Placebo Comparator

Trial Locations (1)

E1 2AX

hVIVO Services Ltd, QMB Bioenterprise building, London

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Prep Biopharm Limited

INDUSTRY

lead

Hvivo

INDUSTRY